Corteva, Inc.

BST:2X0 Stock Report

Market Cap: €37.7b

Corteva Valuation

Is 2X0 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 2X0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 2X0 (€54.31) is trading below our estimate of fair value (€68.73)

Significantly Below Fair Value: 2X0 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2X0?

Key metric: As 2X0 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 2X0. This is calculated by dividing 2X0's market cap by their current earnings.
What is 2X0's PE Ratio?
PE Ratio57.8x
EarningsUS$670.00m
Market CapUS$38.72b

Price to Earnings Ratio vs Peers

How does 2X0's PE Ratio compare to its peers?

The above table shows the PE ratio for 2X0 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average49.9x
SDF K+S
75.1x57.3%€1.9b
BAS BASF
76.5x31.4%€38.0b
SY1 Symrise
36.5x13.7%€14.3b
HEI Heidelberg Materials
11.6x8.7%€21.5b
2X0 Corteva
57.8x26.8%€38.7b

Price-To-Earnings vs Peers: 2X0 is expensive based on its Price-To-Earnings Ratio (57.8x) compared to the peer average (49.9x).

Price to Earnings Ratio vs Industry

How does 2X0's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
2X0 57.8xIndustry Avg. 17.2xNo. of Companies11PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 2X0 is expensive based on its Price-To-Earnings Ratio (57.8x) compared to the European Chemicals industry average (17.2x).

Price to Earnings Ratio vs Fair Ratio

What is 2X0's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2X0 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio57.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 2X0's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 2X0 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€64.10
0%
7.9%€71.37€54.98n/a22
Dec ’25€58.93
€62.66
+6.3%
6.9%€67.73€54.38n/a22
Nov ’25€55.58
€59.21
+6.5%
7.6%€64.72€50.85n/a22
Oct ’25€51.55
€56.80
+10.2%
7.3%€62.98€49.48n/a22
Sep ’25€49.49
€56.80
+14.8%
7.3%€62.98€49.48n/a22
Aug ’25€51.65
€58.64
+13.5%
6.5%€64.87€51.90n/a21
Jul ’25€49.42
€58.90
+19.2%
6.8%€65.20€50.30n/a21
Jun ’25n/a
€58.67
0%
6.8%€64.53€49.78n/a20
May ’25n/a
€58.46
0%
7.5%€65.58€49.65n/a23
Apr ’25€52.50
€57.20
+9.0%
7.7%€64.89€49.13n/a23
Mar ’25n/a
€57.03
0%
7.4%€64.76€49.04n/a24
Feb ’25€50.00
€54.44
+8.9%
9.9%€64.40€46.00n/a24
Jan ’25n/a
€53.70
0%
9.6%€65.36€45.52n/a24
Dec ’24n/a
€53.70
0%
9.6%€65.36€45.52€58.9324
Nov ’24€44.65
€61.88
+38.6%
10.7%€77.24€49.92€55.5823
Oct ’24n/a
€65.04
0%
8.2%€77.42€53.82€51.5522
Sep ’24n/a
€63.46
0%
8.3%€75.40€52.41€49.4922
Aug ’24€50.30
€63.13
+25.5%
8.3%€74.13€51.53€51.6523
Jul ’24n/a
€65.50
0%
7.2%€75.13€55.89€49.4223
Jun ’24n/a
€66.89
0%
7.8%€80.86€56.69n/a22
May ’24n/a
€66.50
0%
8.1%€79.37€54.74n/a21
Apr ’24n/a
€68.53
0%
7.8%€81.58€56.26€52.5021
Mar ’24n/a
€68.03
0%
8.1%€81.21€56.00n/a21
Feb ’24n/a
€67.20
0%
7.7%€79.95€56.98€50.0021
Jan ’24n/a
€68.29
0%
7.8%€82.09€58.50n/a20

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 15:59
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Corteva, Inc. is covered by 41 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Benjamin TheurerBarclays
Adrien TamagnoBerenberg